Tag: zanidatamab-hrii

A sleeping patient in a hospital bed with an IV drip, a clock showing time, and light shining from a lamp, suggesting themes of sleep, time, and chemotherapy treatment.

Zanidatamab-hrii combinations improved survival in first-line HER2-positive advanced gastroesophageal adenocarcinoma

by2 Minute Medicine

October 27, 2026

Company-reported phase 3 results showed sustained survival with zanidatamab-hrii combinations in first-line HER2-positive advanced gastroesophageal adenocarcinoma.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.